Medpace Holdings Q3 2026 Results: Net Income $137M, Up 23.7% YoY
Medpace reported net income of $137.5 million for the third quarter of 2026, up from $111.1 million in the prior year period, driven by an 8.5% increase in net revenue to $716.0 million. For the nine months ended September 30, 2026, net cash provided by operating activities remained strong at $530.4 million, while the company continued its share repurchase program, spending $294.8 million year-to-date.
- Key figure
- Net income $137M · +23.7% YoY